DNMT3A and prostate carcinoma: In this study, we demonstrated that the overexpression of DNMT3a effectively abrogated the SChLAP1 silencing-induced alterations of prostate cancer cell proliferation, migration, and tumor formation in nude mice, as well as miRNA expressional changes.